AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2015

Sep 28, 2015

5229_dirs_2015-09-28_3cce95f6-83b0-402c-944b-3ca9905500e8.html

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4004A

AstraZeneca PLC

28 September 2015

Transactions by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 28 September 2015, Marc Dunoyer, Chief Financial Officer, a person discharging managerial responsibilities, was granted an option under the terms of the AstraZeneca PLC 2012 Savings Related Share Option Scheme over the Company's Ordinary Shares of US$0.25 each.


Name	Number of shares under option	Exercise price per share
Marc Dunoyer	544	3307p

The option will vest and become exercisable on 1 December 2018.

A C N Kemp

Company Secretary

28 September 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUWOARVAAKUAR

AI assistant

AstraZeneca PLC — Director's Dealing 2015

5229_dirs_2015-09-28_3cce95f6-83b0-402c-944b-3ca9905500e8.html

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

More from AstraZeneca PLC

AstraZeneca PLC Director's Dealing 2015